logo-loader

Unilife Corporation to reveal 'commercial contract'

Published: 00:00 13 May 2013 EDT

no_picture_pai

Unilife Corporation's (ASX: UNS, NASDAQ: UNIS) CDI's have been placed in pre-open today, following the ASX granting the company a trading halt pending an announcement regarding a 'commercial contract'.

Unilife is a developer and supplier of injectable drug delivery systems.

In April the company signed a 15-year customisation and commercial supply contract with a U.S. pharmaceutical company for the EZMix™ dual-chamber syringe, with the contract expected to generate up to $110 million.

The halt we last until the earlier of an announcement being made to the market, or the opening of trade on Wednesday 15th May 2013.

 

Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX “Small and Mid-cap” stocks with distribution in Australia, UK, North America and Hong Kong / China.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

3 hours, 41 minutes ago